113 related articles for article (PubMed ID: 20578941)
1. Tissue-specific expression profiling of receptor for advanced glycation end products and its soluble forms in esophageal and lung cancer.
Jing RR; Cui M; Sun BL; Yu J; Wang HM
Genet Test Mol Biomarkers; 2010 Jun; 14(3):355-61. PubMed ID: 20578941
[TBL] [Abstract][Full Text] [Related]
2. Effect of chronic hypoxia on RAGE and its soluble forms in lungs and plasma of mice.
Gopal P; Gosker HR; Theije CC; Eurlings IM; Sell DR; Monnier VM; Reynaert NL
Biochim Biophys Acta; 2015 May; 1852(5):992-1000. PubMed ID: 25703138
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specific expression patterns of the RAGE receptor and its soluble forms--a result of regulated alternative splicing?
Schlueter C; Hauke S; Flohr AM; Rogalla P; Bullerdiek J
Biochim Biophys Acta; 2003 Oct; 1630(1):1-6. PubMed ID: 14580673
[TBL] [Abstract][Full Text] [Related]
4. Endogenous secretory receptor for advanced glycation end products in non-small cell lung carcinoma.
Kobayashi S; Kubo H; Suzuki T; Ishizawa K; Yamada M; He M; Yamamoto Y; Yamamoto H; Sasano H; Sasaki H; Suzuki S
Am J Respir Crit Care Med; 2007 Jan; 175(2):184-9. PubMed ID: 17023736
[TBL] [Abstract][Full Text] [Related]
5. Alternative splicing of the murine receptor for advanced glycation end-products (RAGE) gene.
Kalea AZ; Reiniger N; Yang H; Arriero M; Schmidt AM; Hudson BI
FASEB J; 2009 Jun; 23(6):1766-74. PubMed ID: 19164451
[TBL] [Abstract][Full Text] [Related]
6. Identification of mouse orthologue of endogenous secretory receptor for advanced glycation end-products: structure, function and expression.
Harashima A; Yamamoto Y; Cheng C; Tsuneyama K; Myint KM; Takeuchi A; Yoshimura K; Li H; Watanabe T; Takasawa S; Okamoto H; Yonekura H; Yamamoto H
Biochem J; 2006 May; 396(1):109-15. PubMed ID: 16503878
[TBL] [Abstract][Full Text] [Related]
7. Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms.
Sterenczak KA; Willenbrock S; Barann M; Klemke M; Soller JT; Eberle N; Nolte I; Bullerdiek J; Murua Escobar H
Gene; 2009 Apr; 434(1-2):35-42. PubMed ID: 19061941
[TBL] [Abstract][Full Text] [Related]
8. Effect of insulin on the soluble receptor for advanced glycation end products (RAGE).
Lam JK; Wang Y; Shiu SW; Wong Y; Betteridge DJ; Tan KC
Diabet Med; 2013 Jun; 30(6):702-9. PubMed ID: 23432638
[TBL] [Abstract][Full Text] [Related]
9. Receptor for advanced glycation end products (RAGE) and its ligand, amphoterin are overexpressed and associated with prostate cancer development.
Ishiguro H; Nakaigawa N; Miyoshi Y; Fujinami K; Kubota Y; Uemura H
Prostate; 2005 Jun; 64(1):92-100. PubMed ID: 15666359
[TBL] [Abstract][Full Text] [Related]
10. A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10).
Raucci A; Cugusi S; Antonelli A; Barabino SM; Monti L; Bierhaus A; Reiss K; Saftig P; Bianchi ME
FASEB J; 2008 Oct; 22(10):3716-27. PubMed ID: 18603587
[TBL] [Abstract][Full Text] [Related]
11. Splice variants of the receptor for advanced glycosylation end products (RAGE) in human brain.
Ding Q; Keller JN
Neurosci Lett; 2005 Jan; 373(1):67-72. PubMed ID: 15555779
[TBL] [Abstract][Full Text] [Related]
12. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha.
Lohwasser C; Neureiter D; Weigle B; Kirchner T; Schuppan D
J Invest Dermatol; 2006 Feb; 126(2):291-9. PubMed ID: 16374460
[TBL] [Abstract][Full Text] [Related]
13. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease.
Ohlmeier S; Mazur W; Salmenkivi K; Myllärniemi M; Bergmann U; Kinnula VL
Proteomics Clin Appl; 2010 Jan; 4(1):97-105. PubMed ID: 21137019
[TBL] [Abstract][Full Text] [Related]
14. Receptor for advanced glycation end-products expression in subcutaneous adipose tissue is related to coronary artery disease.
Rodiño-Janeiro BK; Salgado-Somoza A; Teijeira-Fernández E; González-Juanatey JR; Alvarez E; Eiras S
Eur J Endocrinol; 2011 Apr; 164(4):529-37. PubMed ID: 21282351
[TBL] [Abstract][Full Text] [Related]
15. Extracellular matrix is modulated in advanced glycation end products milieu via a RAGE receptor dependent pathway boosted by transforming growth factor-β1 RAGE.
Serban AI; Stanca L; Geicu OI; Munteanu MC; Costache M; Dinischiotu A
J Diabetes; 2015 Jan; 7(1):114-24. PubMed ID: 24666836
[TBL] [Abstract][Full Text] [Related]
16. The receptor for advanced glycation end products is dispensable in a mouse model of oral and esophageal carcinogenesis.
Mark R; Bermejo JL; Bierhaus A; Plinkert PK; Angel P; Hess J
Histol Histopathol; 2013 Dec; 28(12):1585-94. PubMed ID: 23712426
[TBL] [Abstract][Full Text] [Related]
17. RAGE splicing variants in mammals.
Sterenczak KA; Nolte I; Murua Escobar H
Methods Mol Biol; 2013; 963():265-76. PubMed ID: 23296616
[TBL] [Abstract][Full Text] [Related]
18. [Differential expressions of the receptor for advanced glycation end products in prostate cancer and normal prostate].
Lu B; Song XL; Jia LY; Song FL; Zhao SC; Jiang Y
Zhonghua Nan Ke Xue; 2010 May; 16(5):405-9. PubMed ID: 20684319
[TBL] [Abstract][Full Text] [Related]
19. Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension.
Nakamura K; Yamagishi S; Nakamura Y; Takenaka K; Matsui T; Jinnouchi Y; Imaizumi T
Microvasc Res; 2005 Nov; 70(3):137-41. PubMed ID: 16271939
[TBL] [Abstract][Full Text] [Related]
20. Complex tissue-specific patterns and distribution of multiple RAGE splice variants in different mammals.
López-Díez R; Rastrojo A; Villate O; Aguado B
Genome Biol Evol; 2013; 5(12):2420-35. PubMed ID: 24273313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
